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Lymphoid hyperplasia of gastric mucosa
associated with Helicobacter pylori (HP)
infection represents a preneoplastic con-
dition of the mucosa associated lym-
phoid tissue (MALT), which may evolve to
a B-cell lymphoma. While it is well estab-
lished that the initial neoplastic prolifera-
tion of B cells is antigen-driven and depen-
dent on the helper activity of HP-specific
T cells, it needs to be elucidated which
cytokine or soluble factor(s) promote B-
cell activation and lymphomagenesis.
Herein, we originally report that gastric
MALT lymphoma express high levels of a
proliferation inducing ligand (APRIL), a
novel cytokine crucial in sustaining B-cell
proliferation. By immunohistochemistry,
we demonstrate that APRIL is produced
almost exclusively by gastric lymphoma-
infiltrating macrophages located in close
proximity to neoplastic B cells. We also
show that macrophages produce APRIL
on direct stimulation with both HP and
HP-specific T cells. Collectively, our re-
sults represent the first evidence for an
involvement of APRIL in gastric MALT
lymphoma development in HP-infected
patients. (Blood. 2011;117(24):6612-6616)
Introduction
Helicobacter pylori (HP) colonizes the human gastric mucosa and
triggers a strong local inflammatory response.1 Chronic inflammation
because of the persistence of HP infection can give rise to organized
lymphoid tissue in the gastric mucosa, the so-called mucosa-associated
lymphoid tissue (MALT) that, in a small subset of individuals, can
ultimately progress to low-grade gastric B-cell lymphoma of MALT
type.2 The current model of MALT lymphoma genesis assumes that one
or more neoplastic clones, displaying characteristics of marginal zone B
cells, originate from the organized MALT, colonize and replace the
original follicles and eventually destroy the gastric glands to form
lympho-epithelial lesions.3 Although MALT lymphoma usually grows
slowly and has a low propensity to spread, a small percentage of cases
undergo high-grade transformation. It is generally accepted that, in early
stages of gastric lymphoma development, neoplastic growth is both
antigen-driven and dependent of the helper activity of T cells specific for
HP.2,4 The fact that the eradication of the bacterium leads to regression
of the lymphoma, especially in its early stages, is consistent with such a
postulate.5,6 However, less is known about the role of the host immune
response in MALT lymphoma pathogenesis.
A proliferation inducing ligand (APRIL) is one of the most recently
cloned members of the tumor necrosis factor (TNF) family7-10 expressed
by a variety of immune cells including neutrophils, monocytes, macro-
phages, dendritic cells, and T cells, but also epithelial cells and tumor
cells. By binding to its BCMA and TACI receptors, APRIL promotes
survival and proliferation of B cells as well as their differentiation to
plasma cells. As recently reported, APRIL-transgenic mice develops
lymphoid malignancies originating from peritoneal B-1 B cells.11 In
addition, not only APRIL is expressed in a wide array of B-cell
malignancies, including Hodgkin lymphomas,12 but high levels of
APRIL in the serum of these patients correlate with poor prognosis.13
Consistently, in vitro experiments have clearly shown that APRIL
promotes cell survival and proliferation of neoplastic B-cells (reviewed
by Planelles et al13 and Roosnek et al14). Interestingly,APRILexpression
in human non-Hodgkin B-cell lymphomas is found in neoplastic cells as
well as in associated inflammatory cells, predominantly neutrophils.15
Herein, we report that gastric MALT lymphomas are particu-
larly enriched in APRIL-expressing macrophages. We also show
that, in vitro, HP triggers an abundant release of APRIL by human
monocyte-derived macrophages and that HP-specific T cells con-
tribute to create an APRIL-enriched environment in MALT lym-
phoma. Collectively, our results provide the first evidence that




Tissues were obtained from the archive of the Department of Pathology
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and Padova Hospital). Samples included normal gastric mucosa (5 cases),
HP-associated gastric lymphoid infiltrates Wotherspoon-Isaacson
(WI)6grades 1 (5 cases), 3 (3 cases), 4 (2 cases), and 5 (9 cases, resection
specimens), gastric diffuse large B-cell lymphomas (5 cases) and HP-
negative gastritis (6 cases). In the latter group HP was assessed by histology
(modified Giemsa staining) and confirmed by clinical history, rapid urease
testing, and/or ELISA (Hp-specific IgG antibodies; Gastropanel, Biohit). A
second group of samples consisted of matched endoscopic biopsies (pre-
and posttreatment) from 6 patients with gastric MALT lymphoma who
underwent clinical and histologic remission after HP-eradication therapy.
WI-5 cases lack AP12/MALT1 translocation as proved by FISH analysis
(MALT1 FISH deoxyribonucleic acid Probe; Split Signal; Dako Cytoma-
tion) and the large majority of them (7 of 9; 78%) show IgH clonal
rearrangements. For the IgH clonality assay, genomic deoxyribonucleic
acid was extracted from tumor tissue sections using the QIAamp Tissue Kit
(QIAGEN). PCR was performed using genomic deoxyribonucleic acid
(200 ng) with primers targeting the variable region FR2 or FR3 and joining
regions of the IgH gene. The amplified products were visualized in 10%
polyacrylamide gel.
Immunohistochemistry
Four micron formalin-fixed paraffin embedded tissue sections were stained
with anti-APRIL (Ms IgG1, Clone Aprily-2, Alexis Biochemicals) and
anti-HP TMDU (Ms, Clone W4-1; provided by Prof Eishi, Department of
Human Pathology, Graduate School of Medical Science, Tokyo Medical
and Dental University, Tokyo, Japan).16 On appropriate antigen retrieval
(water bath at 98°C for 40 minutes in ethylenediaminetetraacetic acid
buffer pH 8.0), reactivity was revealed using NovoLink Polymer horserad-
ish peroxidase linked (Novocastra Laboratories) followed by Diaminoben-
zidine (DAB). Characterization of APRIL positive cells was performed by
double immunohistochemistry. After completing the first immune reaction,
the second was realized using primary antibodies to the following antigens:
CD11c (Clone 5D11; Novocastra Laboratories Ltd); CD68 (Clone KP-1;
Dako); CD20 (Clone L26; Dako); CD163 (Clone 10D6; Thermo Scientific);
CD1a (Clone 010; Dako); CD15 (Clone MMA; Thermo Scientific) and
visualized using Mach 4-AP (Biocare Medical), followed by Ferangi Blue
(Biocare Medical) as chromogen. Quantification of APRIL-expressing cells
was performed on at least 5 HPF (high power field) on sections double
stained for APRIL and CD11c. Immunostained sections were photographed
using the DP-70 Olympus digital camera mounted on the Olympus BX60
microscope, and the digital pictures (each corresponding to 0.036 mm2)
were used for cell count. Values were expressed as the mean SD.
Bacteria and culture conditions
HP strain 342 was maintained in 5% CO2 at 37°C on Columbia agar plates
supplemented with 5% horse blood. Colonies were inoculated into brain
heart infusion broth containing 5% fetal bovine serum and were cultured for
2 days in rotary shaking at 180 revolutions per minute at 37°C under
microaerophilic conditions.
Macrophage differentiation
Monocytes (5  105) isolated form buffy-coat and seeded in 24-well plates
were cultured in RPMI 20% FBS in the presence of macrophage colony
stimulating factor (M-CSF; Immunologic Science; 100 ng/mL) for a 6-day
differentiation to M-CSF–differentiated human macrophages (MDM).
MDM were cultured for 1 day in culture medium without M-CSF, before
being exposed to bacteria (5 105 colony-forming unit/mL).
Real-time PCR analysis
Total RNA was isolated from MDM using TRIzol solution (Invitrogen)
according to the manufacturer’s instructions. RNA was reverse-transcribed
and amplified with the following primers: for GAPDH, 5-AGCAA-
CAGGGTGGTGGAC-3 and 5-GTGTGGTGGGGGACTGAG-3; for
APRIL, 5-AAGGGTATCCCTGGCAGAGT-3 and 5-GCAGGACA-
GAGTGCTGCTT-3. After the amplification, data analysis was performed
using the second derivative method algorithm. For each sample, the amount
of messenger RNA (mRNA) of APRIL was expressed as the n-fold of the
normalized amount of mRNA in untreated cells (1 arbitrary unit APRIL
mRNA concentration/GAPDH mRNA concentration [both in fmoles/L]).
Generation of gastric T-cell clones and assay for T-cell clone
helper function for APRIL production
On approval of the local Ethical Committee (Department of Internal Medicine,
University of Firenze), 5 HP-positive patients with gastric low-grade MALT
lymphoma and 5 patients with uncomplicated HP-positive chronic gastritis gave
their informed consent and were enrolled in the study. None of the patients had
taken antibiotics or gastric proton pump inhibitors within 2 months before the
study. Biopsy specimens were obtained during endoscopy from the gastric
mucosa for (1) histology and HP detection, (2) rapid urease test, and (3) culture of
infiltrating lymphocytes. Diagnosis of HP infection was based on positive urease
test, histologic detection of HP, and positive 13C-urea breath test. Biopsy
specimens of gastric mucosa were cultured for 7 days in complete medium
supplemented with IL-2 (50 U/mL) to preferentially expand in vivo–activated T
cells. Mucosal specimens were then disrupted, and single T-cell blasts were
cloned by limiting dilution (0.3 cells/well) in round-bottom microwell plates
containing 105 irradiated PBMCs as feeder cells, phytohaemagglutinin (0.5%
vol/vol; Life Technologies) and IL-2 (20 U/mL). Cell surface marker analysis of
T-cell clones was performed on a BD FACSCalibur, according to the CellQuest
Version 5.1 software, using anti-CD3, anti-CD4, and anti-CD8 mAb purchased
from BD. T-cell clones were then screened in triplicate cultures for responsive-
ness to medium or HP lysate (10g/mL) by measurement of [3H]thymidine
deoxyribose uptake after 60 hours in the presence of autologous PBMCs
(5 104) as antigen presenting cells. Mitogenic index (ratio of mean counts per
minute of stimulated to unstimulated cultures)  5 were considered positive.
T-cell blasts of HP-specific clones (8 105/mL) were cocultured for 16 hours
with autologous macrophages (4 105/mL) in the presence of medium or HP
antigen (10g/mL).
APRIL protein detection in cells and in culture supernatant
For the evaluation of the intracellular APRIL content, cells were collected
and lysed in 20mM tris(hydroxymethyl)aminomethane, 150mM NaCl
0.25% NP40 at 4°C. Five micrograms of proteins were loaded on 4%-12%
SDS-PAGE and transferred on nitrocellulose. APRIL was revealed using a
specific mAb (Alexis Biochemical). The amount of extracellular APRIL
was quantified by a commercial ELISA (Invitrogen), according to the
manufacturer’s instructions. For the evaluation of the intracellular APRIL
content, MDM exposed to HP were spread by cytospin on slides and stained
for APRIL as indicated in “Immunohistochemistry.”
Statistical analysis
Data are reported as the mean SD. The Student t test and 1-way ANOVA
were used for statistical analysis of the differences between experimental
groups. P values .05 were considered significant.
Results
HP-associated gastritis and gastric MALT lymphoma are
enriched in APRIL-containing tumor-associated macrophages
We initially evaluated by immunohistochemistry whether APRIL
might be expressed in gastric MALT lymphomas. To this end,
9 cases of HP-associated WI-5 cases lacking the API2/MALT1
translocation, as detected by FISH analysis (not shown), were used.
Compared with normal gastric mucosa, in which APRIL reactivity
is scanty (Figure 1A), we found numerous cells reacting to
anti-APRIL in all WI-5 cases (Figure 1B). The large proportion of
APRIL cells showed a macrophage-like morphology and were
admixed with CD20 neoplastic B cells (Figure 1B inset) and to
surrounding plasma cells (not shown). By double immunohisto-
chemistry of 5 representative cases, APRIL cells were negative
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for lymphoid markers CD20 and CD3 (Figure 1B inset and data not
shown) but strongly reacting to CD11c, CD68 and CD163 but not
to CD1a, thus confirming their macrophage identity (Figure 1D-F
and data not shown). In addition to macrophages, a very small
fraction of CD15 polymorphonuclear cells also reacted to APRIL
(not shown), while, in all cases, no reactivity for APRIL was
observed in the large majority of neoplastic cells (Figure 1B-F). A
further characterization of APRIL reactivity revealed numerous
APRIL macrophages also in HP-associated WI grade 1 to
4 (Figure 1C). Of note, the number of APRIL-producing macro-
phages was significantly higher in WI lesions compared with
normal gastric mucosa and HP-negative gastritis, being the mean
number of CD11c APRIL cells, respectively 22.2 [WI-1],
22.6 [WI-3/4], and 28.5 [WI-5] vs 7.2 [normal mucosa] and
9.2 [HP-negative gastritis] (P  .01); on the contrary, differences
among WI groups were not significant (P  .07). Remarkably, in
matched biopsies obtained from 6 MALT lymphoma patients, the
number of CD11cAPRIL macrophages was dramatically re-
duced (19.6 vs 4.1; P  .01) in WI-5 cases, which underwent
remission after HP-eradication treatment (Figure 1C). Notably,
local production of APRIL was not exclusive of MALT lympho-
mas, because numerous CD11cAPRIL cells were observed also
in cases of HP-negative gastric diffuse large B-cell lymphomas
(not shown).
Together, these results strongly support the notion that macro-
phages represent a relevant source of APRIL available from the
early phases of MALT lymphoma progression.
HP-infected macrophages produce APRIL
It was recently reported that cells containing HP-derived products
can be found in the lamina propria of patients with gastric cancer
and chronic gastritis,16 confirming early and more recent studies
proving that mucosal invasion by HP might occur in HP-dependent
pathologies.17-20 Using the same antibody (recognizing an HP-
specific form of LPS),16 we were able to confirm this finding on
cases of WI grade 1 densely colonized by HP. In particular, in
addition to its classic localization in the gastric surface epithelium
or in the spaces between mucous-secreting cells, we detected
anti-HP reactivity within the cytoplasm of macrophages localized
in multiple foci in the gastric lamina propria (Figures 1G-H).
Remarkably, HP-containing macrophages were positive for CD11c,
CD163 and CD68 (Figure 1I-K), as well as intensely stained by the
anti-APRIL antibody (Figure 1L). In parallel with these tissue
sample evaluations, we subsequently addressed whether HP could
trigger, directly or indirectly, APRIL production by macrophages in
vitro. APRIL, which is barely detectable in freshly purified
monocytes, is actively produced at mRNA and protein level during
monocytes differentiation to macrophages (Figure 2A-B); how-
ever, as quantified by ELISA of the culture supernatant (not
shown), APRIL was not significantly released at any time point
during the culture. HP exposure of MDM induces a time-dependent
expression of APRIL mRNA (Figure 2C) in parallel with the
extracellular accumulation of the related mature protein (Figure
2D). Addition of HP to MDM also triggered a time-dependent
accumulation of intracellular APRIL (Figure 2E).
HP-specific T helper (Th) clones stimulate APRIL production
from autologous macrophages
Proliferation of neoplastic B cells in MALT lymphoma is sustained
by both the antigen and the tumor-infiltrating helper T cells.21 To
test the hypothesis that HP-specific T cells might sustain macro-
phage-derived APRIL production, we studied the helper function of
Figure 1. APRIL production by tissue macrophages.
Sections are from normal gastric mucosa (A), WI grade
5 (B,D-F) and grade 1 (G-L). Compared with normal
gastric mucosa where APRIL reactivity is observed in rare
large cells of the lamina propria (A), numerous APRIL
cells are found (B-C) surrounding CD20 neoplastic cells
in MALT lymphoma (panel B inset) [red symbol in panel C
indicates significance vs normal and G/HP- (#P  .01) or
vs mWI-5/PT (##P  .01)]. Double staining demonstrates
that APRIL cells coexpress CD11c (D), CD68 (E), and
CD163 (F). No APRIL reactivity is observed in neoplastic
B cells (B,D-F). In WI grade 1, the anti-HP antibody
recognizes bacilli in the gastric mucous layer (panel G
inset); HP reactivity is also observed in the cytoplasm of
numerous cells in the gastric lamina propria (H). Double
stain demonstrates that HP-containing cells are repre-
sented by macrophages coexpressing CD11c (I), CD163
(J), and CD68 (K) and some of them produce APRIL (L).
For immunohistochemistry, sections are counterstained
with Meyer haematoxylin and secondary antibodies re-
vealed with DAB (brown, anti-APRIL in panels A,B-
D,E,F,L; anti-HP in panels G-K), and Ferangi blue (blue,
anti-CD11c in panels D,I; anti-CD68 in panels E,K;
anti-CD163 in panels F,J; APRIL in panel L). Scale bar:
100 m (panels A,B,G) and 20 m (panels D-F,I-L).
Legend in panel C: G/HP- indicates HP-negative gastri-
tis; mWI-5, matched WI-5; and mWI-5/PT, matched
WI-5 posteradication treatment.
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clones of ex vivo freshly purified T cells obtained from antral
biopsies of 5 patients with uncomplicated HP chronic gastritis and
5 HP-associated gastric low-grade MALT lymphoma (see “Genera-
tion of gastric T-cell clones and assay for T-cell clone helper
function for APRIL production” for details). By measuring the
[3H]thymidine deoxyribose uptake, we screened our T-cell clones
for HP-induced proliferation in MHC-restricted conditions and
obtained 71 HP-specific Th clones from patients with HP-
associated low-grade MALT lymphoma and 50 HP-specific Th
clones from patients with HP chronic gastritis without MALT
lymphoma. To test the helper ability of HP-specific T cells for
APRIL production, HP-specific T-cell clones were cocultured for
16 hours with autologous monocyte-derived macrophages in the
presence of HP antigen. Remarkably, as demonstrated by ELISA,
HP-specific Th clones from chronic gastritis and, even more
strongly, those purified from MALT lymphoma cases, were able to
stimulate the production of variable amounts of APRIL protein in
an antigen-specific manner (Figure 2F).
Discussion
In this study, we have demonstrated that HP infection in the gastric
mucosa might sustain the local production of APRIL, a tumor
necrosis factor superfamily member known to be important for
B-cell development, maturation, and survival. In particular, numer-
ous APRIL-producing macrophages are found in HP-infected
chronic gastritis and mucosa-associated lymphoid tissue lym-
phoma biopsies, while they are very rare in normal mucosa.
Notably, a fraction of APRIL-positive macrophages contain HP-
derived products; moreover, in vitro HP infection induces expres-
sion of APRIL in monocyte-derived macrophages, thus indicating a
primary role of the bacterium in promoting monocyte-derived cells
to produce APRIL in infected gastric mucosa.
A large body of experimental and clinical evidence suggest that
APRIL sustains B-cell transformation and progression of B-cell
lymphomas.11-14 Different forms of B-cell lymphoma were found to
contain APRIL-positive cells, that were represented either by
neoplastic B-cells and by tumor associated immune cells,13 includ-
ing macrophages.22 In keeping with these observations we have
documented that APRIL macrophages are also abundant in gastric
diffuse large B-cell lymphomas devoid of HP infection. These
observations indicate that the induction of APRIL in lymphomas
partially reflect the local activation of tumor-associated macro-
phages likely mediated by different mechanisms. Craxton et al
reported that human macrophages but not monocytes or monocyte-
derived dendritic cells constitutively express high levels of APRIL.23
Furtermore, the expression of APRIL has been detected in
macrophage-like cell lines, monocyte-derived macrophages and
inflammatory macrophages.23-27 Stimuli mediating APRIL release
by macrophages are largely unknown. We found that APRIL is
gradually induced but not released by macrophages during M-CSF–
dependent differentiation from monocytes. However, we provide
evidence that APRIL release by macrophages depends on HP,
either after a direct stimulation by the bacteria, or by HP-specific
T cells, especially those purified from overt MALT B-cell
lymphoma.
The role of HP in gastric MALT lymphoma is well established,
considering that chronic HP antigen stimulation is essential for
their progression. Survival and proliferation of transformed B-cells
in gastric MALT lymphoma require signals from tumor-associated
T-cells or direct auto-antigen stimulation of neoplastic cells.
Figure 2. APRIL production during macrophage differentiation and exposure to
HP or to HP-specific T cells. Monocytes exposed to M-CSF were harvested at the
indicated time points and APRIL mRNA was quantified by real-time PCR (A); in
parallel the APRIL protein cell content was determined by Western blot. GAPDH was
used as marker of equal loading (B). M-CSF–differentiated macrophages (MDM)
were exposed to HP (5  105 colony-forming unit/mL). At the indicated time points
cells were harvested for mRNA evaluation (C) and culture supernatant collected for
APRIL content determination (D); AU indicates arbitrary units. In parallel, MDM
cytospins were labeled for their intracellular APRIL content (E). HP-specific Th cells
isolated from MALT lymphoma patients and from chronic gastritis patients were
cocultured with autologous macrophages in the presence of medium or HP antigens
and the APRIL production was assessed by ELISA (F). Results represent the APRIL
levels induced by T-cell clones over the APRIL production in cultures of macrophages
alone. ***P  .01
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(reviewed in Isaacson and Du3 and D’Elios et al21). Our data
suggest that tumor-associated macrophages might sustain progres-
sion of MALT lymphoma by releasing APRIL. We propose that
HP-driven gastric inflammation leads to the generation of a local
pool of macrophages that on HP infection release large amount of
APRIL. This functional loop can be further amplified and perpetu-
ated by HP-specific T cells. Remarkably, as proof of principle of
this postulate, APRIL-producing macrophages are dramatically
reduced on lymphoma remission induced by HP eradication.
Our results provide a new piece of information to HP-
dependent MALT lymphomagenesis pointing to tumor-associated
macrophages as contributors of tumor progression via APRIL
release. Thus, based on these findings, we suggest that, among
biologic therapies targeting B cells,28 blockade of APRIL might
represent a novel additional therapeutic strategy for gastric MALT
lymphoma, supporting the notion that the targeting tumor-
associated macrophages and their products can be particularly
relevant in lymphoid malignancies.29-30
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